{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:49:41Z","timestamp":1790812181401,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T00:00:00Z","timestamp":1739059200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002631","name":"Gachon University","doi-asserted-by":"publisher","award":["GCU-202008420013"],"award-info":[{"award-number":["GCU-202008420013"]}],"id":[{"id":"10.13039\/501100002631","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["NRF-2018R1A5A2024425"],"award-info":[{"award-number":["NRF-2018R1A5A2024425"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["NRF-2021R1A2C1005520"],"award-info":[{"award-number":["NRF-2021R1A2C1005520"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jare.2025.02.012","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T12:15:40Z","timestamp":1739362540000},"page":"681-702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Blocking S1P4 signaling attenuates brain injury in mice with ischemic stroke"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2326-3463","authenticated-orcid":false,"given":"Nikita","family":"Basnet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunkyung","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Sapkota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungbae","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaemin","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9738-6493","authenticated-orcid":false,"given":"Bhakta Prasad","family":"Gaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo-Youn","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hui","family":"Been","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5483-0016","authenticated-orcid":false,"given":"Seunghee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bong Yong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Woong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanghee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10306","key":"10.1016\/j.jare.2025.02.012_b0005","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S0140-6736(21)00244-0","article-title":"Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions","volume":"398","author":"McGinley","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jare.2025.02.012_b0010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s40265-020-01431-8","article-title":"Sphingosine 1-phosphate Receptor modulator therapy for multiple sclerosis: differential downstream receptor signalling and clinical profile effects","volume":"81","author":"Chun","year":"2021","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.jare.2025.02.012_b0015","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1038\/s41467-023-38069-5","article-title":"Revealing concealed cardioprotection by platelet Mfsd2b-released S1P in human and murine myocardial infarction","volume":"14","author":"Polzin","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2025.02.012_b0020","article-title":"Targeting sphingosine-1-phosphate signaling to prevent the progression of aortic valve disease","author":"Benkhoff","year":"2024","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.jare.2025.02.012_b0025","doi-asserted-by":"crossref","first-page":"6377","DOI":"10.1016\/j.bmcl.2013.09.058","article-title":"Modulators of the Sphingosine 1-phosphate receptor 1","volume":"23","author":"Urbano","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"issue":"12","key":"10.1016\/j.jare.2025.02.012_b0030","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1007\/s00044-022-02961-4","article-title":"Sphingosine 1-phosphate receptor modulators for the treatment of inflammatory bowel disease and other immune-mediated diseases","volume":"31","author":"Xu","year":"2022","journal-title":"Med Chem Res"},{"issue":"7","key":"10.1016\/j.jare.2025.02.012_b0035","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1517\/13543776.2013.783022","article-title":"Sphingosine 1-phosphate receptor agonists: a patent review (2010-2012)","volume":"23","author":"Roberts","year":"2013","journal-title":"Expert Opin Ther Pat"},{"issue":"4","key":"10.1016\/j.jare.2025.02.012_b0040","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1517\/13543776.2016.1157165","article-title":"Sphingosine 1-phosphate receptor 1 agonists: a patent review (2013-2015)","volume":"26","author":"Guerrero","year":"2016","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.jare.2025.02.012_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113923","article-title":"Novel 5-fluorouracil sensitizers for colorectal cancer therapy: design and synthesis of S1P receptor 2 (S1PR2) antagonists","volume":"227","author":"Luo","year":"2022","journal-title":"Eur J Med Chem"},{"issue":"11","key":"10.1016\/j.jare.2025.02.012_b0050","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1111\/bph.13476","article-title":"Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1) and receptor-5 (S1P5) agonist with autoimmune disease-modifying activity","volume":"173","author":"Scott","year":"2016","journal-title":"Br J Pharmacol"},{"issue":"5","key":"10.1016\/j.jare.2025.02.012_b0055","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/j.1476-5381.2012.02061.x","article-title":"The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate","volume":"167","author":"Gergely","year":"2012","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.jare.2025.02.012_b0060","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1182\/blood-2005-07-2628","article-title":"Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720","volume":"107","author":"Zemann","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jare.2025.02.012_b0065","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/6059203","article-title":"Beyond immune cell migration: the emerging role of the sphingosine-1-phosphate receptor S1PR4 as a modulator of innate immune cell activation","volume":"2017","author":"Olesch","year":"2017","journal-title":"Mediators Inflamm"},{"issue":"9","key":"10.1016\/j.jare.2025.02.012_b0070","doi-asserted-by":"crossref","first-page":"7348","DOI":"10.1074\/jbc.M110.171819","article-title":"Sphingosine-1-phosphate lyase deficiency produces a pro-inflammatory response while impairing neutrophil trafficking","volume":"286","author":"Allende","year":"2011","journal-title":"J Biol Chem"},{"issue":"6\u20137","key":"10.1016\/j.jare.2025.02.012_b0075","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1515\/hsz-2014-0271","article-title":"S1PR4 is required for plasmacytoid dendritic cell differentiation","volume":"396","author":"Dillmann","year":"2015","journal-title":"Biol Chem"},{"issue":"8","key":"10.1016\/j.jare.2025.02.012_b0080","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/ng.3607","article-title":"Meta-analysis of rare and common exome chip variants identifies S1PR4 and other loci influencing blood cell traits","volume":"48","author":"C.C.H.W. Group","year":"2016","journal-title":"Nat Genet"},{"issue":"11","key":"10.1016\/j.jare.2025.02.012_b0085","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1096\/fj.10-179028","article-title":"Sphingosine-1-phospate receptor 4 (S1P4) deficiency profoundly affects dendritic cell function and TH17-cell differentiation in a murine model","volume":"25","author":"Schulze","year":"2011","journal-title":"Faseb J"},{"issue":"6","key":"10.1016\/j.jare.2025.02.012_b0090","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/eji.201948349","article-title":"S1PR4-dependent CCL2 production promotes macrophage recruitment in a murine psoriasis model","volume":"50","author":"Schuster","year":"2020","journal-title":"Eur J Immunol"},{"issue":"19","key":"10.1016\/j.jare.2025.02.012_b0095","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.1016\/j.bmcl.2004.07.030","article-title":"Synthesis of benzimidazole based analogues of sphingosine-1-phosphate: discovery of potent, subtype-selective S1P4 receptor agonists","volume":"14","author":"Clemens","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"10.1016\/j.jare.2025.02.012_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bmcl.2016.11.050","article-title":"A benzo[b]thiophene-based selective type 4 S1P receptor agonist","volume":"27","author":"Hur","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"issue":"22","key":"10.1016\/j.jare.2025.02.012_b0105","doi-asserted-by":"crossref","first-page":"6739","DOI":"10.1016\/j.bmcl.2011.09.049","article-title":"Discovery, synthesis and SAR analysis of novel selective small molecule S1P4-R agonists based on a (2Z,5Z)-5-((pyrrol-3-yl)methylene)-3-alkyl-2-(alkylimino)thiazolidin-4-one chemotype","volume":"21","author":"Urbano","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"10.1016\/j.jare.2025.02.012_b0110","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.bmcl.2011.10.096","article-title":"Discovery, design and synthesis of novel potent and selective sphingosine-1-phosphate 4 receptor (S1P4-R) agonists","volume":"22","author":"Guerrero","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jare.2025.02.012_b0115","unstructured":"K. Azzaoui, R. Bouhelal, P. Buehlmayer, D. Guerini, M. Koller, Indol-alanine derivatives as selective S1P4-agonists, Google Patents, 2010. https:\/\/patentscope.wipo.int\/search\/ar\/detail.jsf;jsessionid=6AF7F425822044A1D1C3A8D13C4D4706.wapp1nC?docId=US43204081&_cid=P12-L93MJN-38445-1."},{"issue":"18","key":"10.1016\/j.jare.2025.02.012_b0120","doi-asserted-by":"crossref","first-page":"5470","DOI":"10.1016\/j.bmcl.2011.06.132","article-title":"SAR analysis of innovative selective small molecule antagonists of sphingosine-1-phosphate 4 (S1P4) receptor","volume":"21","author":"Urbano","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"10.1016\/j.jare.2025.02.012_b0125","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jcmgh.2021.12.002","article-title":"Sphingosine 1-phosphate receptor 4 promotes nonalcoholic steatohepatitis by activating NLRP3 inflammasome","volume":"13","author":"Hong","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jare.2025.02.012_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113518","article-title":"Emerging neuroprotective strategies for the treatment of ischemic stroke: an overview of clinical and preclinical studies","volume":"335","author":"Paul","year":"2021","journal-title":"Exp Neurol"},{"issue":"1","key":"10.1016\/j.jare.2025.02.012_b0135","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12017-020-08614-2","article-title":"Sphingosine 1-phosphate receptors in cerebral ischemia","volume":"23","author":"Gaire","year":"2021","journal-title":"Neuromolecular Med"},{"issue":"3","key":"10.1016\/j.jare.2025.02.012_b0140","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1007\/s12035-017-0468-8","article-title":"Identification of sphingosine 1-phosphate receptor subtype 1 (S1P(1)) as a pathogenic factor in transient focal cerebral ischemia","volume":"55","author":"Gaire","year":"2018","journal-title":"Mol Neurobiol"},{"issue":"1","key":"10.1016\/j.jare.2025.02.012_b0145","doi-asserted-by":"crossref","first-page":"12106","DOI":"10.1038\/s41598-019-48609-z","article-title":"S1P(2) contributes to microglial activation and M1 polarization following cerebral ischemia through ERK1\/2 and JNK","volume":"9","author":"Sapkota","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jare.2025.02.012_b0150","doi-asserted-by":"crossref","first-page":"7893","DOI":"10.1038\/ncomms8893","article-title":"Critical role of sphingosine-1-phosphate receptor-2 in the disruption of cerebrovascular integrity in experimental stroke","volume":"6","author":"Kim","year":"2015","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jare.2025.02.012_b0155","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12974-018-1323-1","article-title":"Sphingosine 1-phosphate receptor subtype 3 (S1P(3)) contributes to brain injury after transient focal cerebral ischemia via modulating microglial activation and their M1 polarization","volume":"15","author":"Gaire","year":"2018","journal-title":"J Neuroinflammation"},{"issue":"1","key":"10.1016\/j.jare.2025.02.012_b0160","doi-asserted-by":"crossref","first-page":"8309","DOI":"10.1038\/s41598-019-44845-5","article-title":"Role of the S1P pathway and inhibition by fingolimod in preventing hemorrhagic transformation after stroke","volume":"9","author":"Salas-Perdomo","year":"2019","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.jare.2025.02.012_b0165","first-page":"4701","article-title":"Shaping of terminal megakaryocyte differentiation and proplatelet development by sphingosine-1-phosphate receptor S1P4","volume":"24","author":"Golfier","year":"2010","journal-title":"FASEB J"},{"issue":"4","key":"10.1016\/j.jare.2025.02.012_b0170","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.4049\/jimmunol.1403168","article-title":"S1PR4 signaling attenuates ILT 7 internalization to limit IFN-\u03b1 production by human plasmacytoid dendritic cells","volume":"196","author":"Dillmann","year":"2016","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.jare.2025.02.012_b0175","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/jcbfm.2015.45","article-title":"Targeting neutrophils in ischemic stroke: translational insights from experimental studies","volume":"35","author":"Jickling","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.jare.2025.02.012_b0180","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.bbi.2018.03.009","article-title":"FTY720 attenuates behavioral deficits in a murine model of systemic lupus erythematosus","volume":"70","author":"Shi","year":"2018","journal-title":"Brain Behav Immun"},{"issue":"1","key":"10.1016\/j.jare.2025.02.012_b0185","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/JLB.3A0717-287R","article-title":"Fingolimod targets cerebral endothelial activation to block leukocyte recruitment in the central nervous system","volume":"103","author":"Zhao","year":"2018","journal-title":"J Leukoc Biol"},{"issue":"1","key":"10.1016\/j.jare.2025.02.012_b0190","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ana.22186","article-title":"Fingolimod provides long-term protection in rodent models of cerebral ischemia","volume":"69","author":"Wei","year":"2011","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.jare.2025.02.012_b0195","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bbrc.2011.08.070","article-title":"Activation of sphingosine kinase 2 is an endogenous protective mechanism in cerebral ischemia","volume":"413","author":"Pfeilschifter","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"issue":"7873","key":"10.1016\/j.jare.2025.02.012_b0200","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"issue":"6070","key":"10.1016\/j.jare.2025.02.012_b0205","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1126\/science.1215904","article-title":"Crystal structure of a lipid G protein-coupled receptor","volume":"335","author":"Hanson","year":"2012","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.jare.2025.02.012_b0210","unstructured":"D.S. BIOVIA, Discovery Studio 2024, Dassault Syst\u00e8mes, San Diego, 2024. https:\/\/www.3ds.com\/products\/biovia\/discovery-studio."},{"issue":"11","key":"10.1016\/j.jare.2025.02.012_b0215","article-title":"BMS-986020, a Specific LPA(1) antagonist, provides neuroprotection against ischemic stroke in mice","volume":"9","author":"Gaire","year":"2020","journal-title":"Antioxidants (Basel)"},{"issue":"1","key":"10.1016\/j.jare.2025.02.012_b0220","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/2040-7378-2-13","article-title":"Functional assessments in the rodent stroke model","volume":"2","author":"Schaar","year":"2010","journal-title":"Exp Transl Stroke Med"},{"issue":"1","key":"10.1016\/j.jare.2025.02.012_b0225","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12974-019-1555-8","article-title":"Lysophosphatidic acid receptor 1 (LPA(1)) plays critical roles in microglial activation and brain damage after transient focal cerebral ischemia","volume":"16","author":"Gaire","year":"2019","journal-title":"J Neuroinflammation"},{"issue":"3","key":"10.1016\/j.jare.2025.02.012_b0230","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci10030159","article-title":"Post-ischaemic immunological response in the brain: targeting microglia in ischaemic stroke therapy","volume":"10","author":"Rawlinson","year":"2020","journal-title":"Brain Sci"},{"issue":"1","key":"10.1016\/j.jare.2025.02.012_b0235","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12974-021-02309-6","article-title":"The semantics of microglia activation: neuroinflammation, homeostasis, and stress","volume":"18","author":"Woodburn","year":"2021","journal-title":"J Neuroinflammation"},{"issue":"3","key":"10.1016\/j.jare.2025.02.012_b0240","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0006-291X(02)02237-4","article-title":"Phytosphingosine 1-phosphate: a high affinity ligand for the S1P(4)\/Edg-6 receptor","volume":"297","author":"Candelore","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.jare.2025.02.012_b0245","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.bmc.2016.11.015","article-title":"Computer design, synthesis, and bioactivity analyses of drugs like fingolimod used in the treatment of multiple sclerosis","volume":"25","author":"Turgut","year":"2017","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.jare.2025.02.012_b0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2014.07.081","article-title":"Discovery of oxazole and triazole derivatives as potent and selective S1P(1) agonists through pharmacophore-guided design","volume":"85","author":"Tian","year":"2014","journal-title":"Eur J Med Chem"},{"issue":"10","key":"10.1016\/j.jare.2025.02.012_b0255","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/j.bmc.2016.03.059","article-title":"Synthesis, identification, and biological activity of metabolites of two novel selective S1P1 agonists","volume":"24","author":"Xiao","year":"2016","journal-title":"Bioorg Med Chem"},{"issue":"24","key":"10.1016\/j.jare.2025.02.012_b0260","doi-asserted-by":"crossref","first-page":"21453","DOI":"10.1074\/jbc.C200176200","article-title":"The immune modulator FTY720 targets sphingosine 1-phosphate receptors","volume":"277","author":"Brinkmann","year":"2002","journal-title":"J Biol Chem"},{"issue":"5566","key":"10.1016\/j.jare.2025.02.012_b0265","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1126\/science.1070238","article-title":"Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists","volume":"296","author":"Mandala","year":"2002","journal-title":"Science (New York, N.Y.)"},{"issue":"48","key":"10.1016\/j.jare.2025.02.012_b0270","doi-asserted-by":"crossref","first-page":"47408","DOI":"10.1074\/jbc.M307687200","article-title":"Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases","volume":"278","author":"Billich","year":"2003","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.jare.2025.02.012_b0275","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/(SICI)1097-0282(200003)53:3<233::AID-BIP3>3.0.CO;2-4","article-title":"Evidence for a strong sulfur-aromatic interaction derived from crystallographic data","volume":"53","author":"Zauhar","year":"2000","journal-title":"Biopolymers"},{"issue":"5","key":"10.1016\/j.jare.2025.02.012_b0280","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1189\/jlb.1109766","article-title":"Inflammatory mechanisms in ischemic stroke: role of inflammatory cells","volume":"87","author":"Jin","year":"2010","journal-title":"J Leukoc Biol"},{"issue":"3","key":"10.1016\/j.jare.2025.02.012_b0285","doi-asserted-by":"crossref","DOI":"10.3390\/biom14030305","article-title":"Understanding the pathophysiology of ischemic stroke: the basis of current therapies and opportunity for new ones","volume":"14","author":"Salaudeen","year":"2024","journal-title":"Biomolecules"},{"issue":"10","key":"10.1016\/j.jare.2025.02.012_b0290","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1523\/JNEUROSCI.0188-21.2021","article-title":"Endothelial sphingosine-1-phosphate receptor 4 regulates blood-brain barrier permeability and promotes a homeostatic endothelial phenotype","volume":"42","author":"Hansen","year":"2022","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.jare.2025.02.012_b0295","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ymthe.2019.09.003","article-title":"A NeuroD1 AAV-based gene therapy for functional brain repair after ischemic injury through in vivo astrocyte-to-neuron conversion","volume":"28","author":"Chen","year":"2020","journal-title":"Mole Therapy : J Am Soc Gene Therapy"},{"issue":"2","key":"10.1016\/j.jare.2025.02.012_b0300","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2021.5070","article-title":"Neuronal injuries in cerebral infarction and ischemic stroke: from mechanisms to treatment (Review)","volume":"49","author":"Zhao","year":"2022","journal-title":"Int J Mol Med"},{"issue":"1","key":"10.1016\/j.jare.2025.02.012_b0305","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/jcbfm.2013.188","article-title":"Selective neuronal loss in ischemic stroke and cerebrovascular disease","volume":"34","author":"Baron","year":"2014","journal-title":"J Cereb Blood Flow Metab"},{"issue":"Pt 1","key":"10.1016\/j.jare.2025.02.012_b0310","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/brain\/awh645","article-title":"Apoptosis dominant in the periinfarct area of human ischaemic stroke\u2013a possible target of antiapoptotic treatments","volume":"129","author":"Sairanen","year":"2006","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.jare.2025.02.012_b0315","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nn.4475","article-title":"The role of peripheral immune cells in the CNS in steady state and disease","volume":"20","author":"Prinz","year":"2017","journal-title":"Nat Neurosci"},{"issue":"2","key":"10.1016\/j.jare.2025.02.012_b0320","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00401-014-1381-0","article-title":"Neutrophil recruitment to the brain in mouse and human ischemic stroke","volume":"129","author":"Perez-de-Puig","year":"2015","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.jare.2025.02.012_b0325","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1007\/s12035-019-01844-x","article-title":"Sphingosine 1-phosphate signaling is involved in impaired blood-brain barrier function in ischemia-reperfusion injury","volume":"57","author":"Nakagawa","year":"2020","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.jare.2025.02.012_b0330","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.2147\/JIR.S461795","article-title":"Microglia in ischemic stroke: pathogenesis insights and therapeutic challenges","volume":"17","author":"Shui","year":"2024","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.jare.2025.02.012_b0335","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fncel.2020.00198","article-title":"Overview of general and discriminating markers of differential microglia phenotypes","volume":"14","author":"Jurga","year":"2020","journal-title":"Front Cell Neurosci"},{"issue":"5","key":"10.1016\/j.jare.2025.02.012_b0340","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41583-023-00690-0","article-title":"Neuroimmune mechanisms and therapies mediating post-ischaemic brain injury and repair","volume":"24","author":"Shichita","year":"2023","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.jare.2025.02.012_b0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105419","article-title":"Phytochemicals as regulators of microglia\/macrophages activation in cerebral ischemia","volume":"165","author":"Subedi","year":"2021","journal-title":"Pharmacol Res"},{"issue":"5","key":"10.1016\/j.jare.2025.02.012_b0350","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41423-021-00670-3","article-title":"An update on the regulatory mechanisms of NLRP3 inflammasome activation","volume":"18","author":"Paik","year":"2021","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"10.1016\/j.jare.2025.02.012_b0355","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s11658-023-00462-9","article-title":"The NLRP3 inflammasome: contributions to inflammation-related diseases","volume":"28","author":"Chen","year":"2023","journal-title":"Cell Mol Biol Lett"},{"key":"10.1016\/j.jare.2025.02.012_b0360","doi-asserted-by":"crossref","unstructured":"S.K. Masenga, A.J.F.i.S. Kirabo, The NLRP3 inflammasome in ischemic stroke, 3 (2024) 1382379. doi:10.3389\/fstro.2024.1382379.","DOI":"10.3389\/fstro.2024.1382379"},{"key":"10.1016\/j.jare.2025.02.012_b0365","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bbi.2020.12.009","article-title":"The NLRP3 inflammasome drives inflammation in ischemia\/reperfusion injury after transient middle cerebral artery occlusion in mice","volume":"92","author":"Franke","year":"2021","journal-title":"Brain Behav Immun"},{"issue":"22","key":"10.1016\/j.jare.2025.02.012_b0370","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228595","article-title":"NLRP3 Inflammasome Activation Is involved in LPA(1)-mediated brain injury after transient focal cerebral ischemia","volume":"21","author":"Lee","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.jare.2025.02.012_b0375","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/jcbfm.2013.242","article-title":"NLRP3 deficiency ameliorates neurovascular damage in experimental ischemic stroke","volume":"34","author":"Yang","year":"2014","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"10.1016\/j.jare.2025.02.012_b0380","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nri.2017.125","article-title":"Microglia and macrophages in brain homeostasis and disease","volume":"18","author":"Li","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jare.2025.02.012_b0385","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.633610","article-title":"The role of NF-\u03baB triggered inflammation in cerebral ischemia","volume":"15","author":"Jover-Mengual","year":"2021","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"10.1016\/j.jare.2025.02.012_b0390","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/s12974-020-02031-9","article-title":"Prophylactic inhibition of NF-\u03baB expression in microglia leads to attenuation of hypoxic ischemic injury of the immature brain","volume":"17","author":"Zaghloul","year":"2020","journal-title":"J Neuroinflammation"},{"issue":"4","key":"10.1016\/j.jare.2025.02.012_b0395","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2174\/1871527319666200613223018","article-title":"MAPK: a key player in the development and progression of stroke","volume":"19","author":"Zheng","year":"2020","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"1","key":"10.1016\/j.jare.2025.02.012_b0400","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ana.23948","article-title":"Management of patients with stroke: is it time to expand treatment options?","volume":"74","author":"Adams","year":"2013","journal-title":"Ann Neurol"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123225001109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123225001109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:57:30Z","timestamp":1778835450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123225001109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":80,"alternative-id":["S2090123225001109"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2025.02.012","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blocking S1P4 signaling attenuates brain injury in mice with ischemic stroke","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2025.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}